March 21, 2022— Medidata, a Dassault Systèmes company, has announced a new partnership with S-CLINICA, a move that will bring advanced supply forecasting optimization to Medidata’s Rave RTSM (Randomization and Trial Supply Management) solution.
“The clinical trial eco-system has grown in complexity since the pandemic, and by working with Medidata, we can help sponsors and CROs improve their cost savings and efficiencies by estimating the demand in supplies at any stage of even complex studies,” said Irena Seredina Executive Director at S-CLINICA.
Rave RTSM is the only fully pre-validated randomization and trial supply management solution that can be configured in minutes and enables mid-study changes with minimal downtime. RTSM is built on Rave EDC, the industry’s leading electronic data capture solution, and as part of Medidata’s unified platform, the Medidata Clinical Cloud, it is a key element in conducting clinical trials more efficiently.
“The ability to analyze and forecast supply needs across sites can result in a reduction of supply costs of more than 30-60%, with a more efficient use of resources.” said Kevin Collier, vice president of product management for RTSM at Medidata. “Efficient management and distribution of supplies is an important part of making clinical trials feasible and successful. This technology is becoming more important as we support greater numbers of decentralized trials with an increasing focus on enhancing our sustainability footprint in the industry.”
Contact:
Tom Paolella
Senior Director, Corporate Communications & Affairs
+1-848-203-7596
thomas.paolella@3ds.com
Paul Oestreicher
External Communications Director
+1-917-522-4692
paul.oestreicher@3ds.com